Multiplex PCR tests for respiratory airway infections (e.g. bronchitis, bronchiolitis, etc.) are increasingly being advertised by the industry. While these tests may be helpful in understanding the clinical picture, in particular in patients at higher risk such as former preterm babies, I do not see any point why we should do such tests in normal, otherwise healthy children. The industry promoting such multiplex PCR tests, may say differently, but I do not recognize any impact on clinical or hygiene-management.
Only RSV is relevant, and for this we can do a quick and cheap ELISA, to protect risk patients. The only information of tests in other children could be relevant for epidemiological studies and research.
What do the other colleagues think?